Clinical Preventive Medicine
- Medicaid expansions following the Affordable Care Act have improved insurance coverage in low-income adults, but little is known about its impact on cancer screening. This study examined associations between Medicaid expansion timing and colorectal cancer (CRC) and breast cancer (BC) screening.
- Mutations in BRCA genes are strongly associated with increased risk of breast and ovarian cancer, and it is recommended that women at high risk for these mutations be referred for genetic counseling and testing. The Affordable Care Act (ACA) provision implemented in 2010 eliminated cost sharing for BRCA genetic testing for privately insured women with family history of BRCA-related cancers.
- Recent studies report racial disparities among individuals in organized colorectal cancer (CRC) programs; however, there is a paucity of information on CRC screening utilization by race/ethnicity among newly age-eligible adults in such programs.
- In 2009, the U.S. Preventive Services Task Force (USPSTF) no longer recommended routine mammography for women aged 40–49 and ≥75 years (younger and older women, respectively). Whether mammography usage and physician recommendation among younger and older women changed in response to these recommendations is unclear.
- Chronic hepatitis C virus (HCV) infection is the most common blood-borne pathogen and a leading cause of morbidity and mortality related to liver disease in the U.S.1 There are an estimated 2.7–3.2 million people chronically infected in the U.S., 81% of whom are accounted for by people born between 1945 and 1965 (“baby boomers”).2,3 The majority of infected individuals are unaware of their infections despite the availability of effective treatment.1 In 2012, CDC recommended one-time HCV testing for baby boomers,4 which was endorsed by the U.S.